SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
+36.17%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$311M
AUM Growth
+$311M
(+79%)
Cap. Flow
+$93.5M
Cap. Flow
% of AUM
30.09%
Top 10 Holdings %
Top 10 Hldgs %
74.66%
Holding
36
New
8
Increased
5
Reduced
10
Closed
4
Top Buys
| 1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$73.4M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$12.8M |
| 3 |
Spyre Therapeutics
SYRE
|
$8.95M |
| 4 |
Geron
GERN
|
$8.48M |
| 5 |
Fulcrum Therapeutics
FULC
|
$5.38M |
Top Sells
| 1 |
Liquidia Corp
LQDA
|
$4.78M |
| 2 |
Tempest Therapeutics
TPST
|
$3.97M |
| 3 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$3.47M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2.85M |
| 5 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$2.46M |
Sector Composition
| 1 | Healthcare | 97.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Soleno Therapeutics
SLNO
$3.56B
| $1.67M | 0.54% |
+750,000
| New | +$1.67M |
|
|
UROV
27
DELISTED
Urovant Sciences Ltd.
UROV
| $1.55M | 0.5% |
157,480
| – | – |
|
|
NGM
28
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $959K | 0.31% |
+48,602
| New | +$959K |
|
29
Assembly Biosciences
ASMB
$183M
| $694K | 0.22% |
+29,740
| New | +$694K |
|
30
Akero Therapeutics
AKRO
$3.65B
| $554K | 0.18% |
22,234
-27,766
| -56% | -$692K |
|
|
AMRN
31
Amarin Corp
AMRN
$311M
| $346K | 0.11% |
50,000
-145,195
| -74% | -$1M |
|
|
VRNA
32
Verona Pharma
VRNA
$9.18B
| $203K | 0.07% |
+43,456
| New | +$203K |
|
|
VIRX
33
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-5,938,215
| Closed | -$2.46M |
|
|
34
Tempest Therapeutics
TPST
$46.6M
| – | – |
-751,301
| Closed | -$3.97M |
|
|
35
Liquidia Corp
LQDA
$2.52B
| – | – |
-1,013,773
| Closed | -$4.78M |
|
|
BLUE
36
DELISTED
bluebird bio
BLUE
| – | – |
-24,790
| Closed | -$1.14M |
|